publication date: Aug. 4, 2017

In Brief Ramon Parsons named director of Tisch Cancer Institute at Mt. Sinai

Ramon Parsons was named director of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai effective July 1.

Steven Burakoff, who has served as director of the Institute for a decade, will move into a new role as dean for cancer innovation.

Parsons, the Ward-Coleman Chair in Cancer Research and professor of oncological sciences, is a cancer biologist. He was appointed deputy director of the Tisch Cancer Institute in 2016. Since that time, he has been co-leader of the Cancer Mechanisms Program, which studies cancer signaling, transcription regulation, and biology.

Parsons is also an Icahn Scholar, an honor conferred upon ISMMS faculty who are among the foremost experts in their field and whose work is transforming the face of biomedical science.

As director, Parsons will retain his role as chair of the Department of Oncological Sciences. He will also continue his research program. Among his most important discoveries is the identification of PTEN, a tumor suppressor gene that is often mutated in cancer, which provides critical therapeutic targets in breast, brain, prostate, and endometrial cancers.

Prior to joining the ISMMS faculty in 2013, Parsons served on the Columbia College of Physicians and Surgeons faculty for 18 years. At the time of his departure, he was the Avon Foundation Professor of Pathology … Continue reading Ramon Parsons named director of Tisch Cancer Institute at Mt. Sinai

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.